Clinical Trial: Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients
Study Status: Completed
Recruit Status: Completed
Condition: IBD
Study Type: Observational
Official Title: Adalimumab Versus Ustekinumab in Management of Inflammatory Bowel Disease in Egyptian Patients
Brief Summary:
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory relapsing disorder affecting the gastrointestinal tract and is characterized by a progressive and unpredictable disease course.The two goals of therapy are the achievement of remission (induction) and the prevention of disease flares (maintenance). Medical therapy for IBD has advanced dramatically in the last decade with the introduction of targeted biologic therapies including…
Read more